ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 215

Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors

Geraldine M. McCarthy1, Clare C. Cunningham2, Emma M. Corr3 and Aisling Dunne3, 1University College Dublin, Dublin, Ireland, 2School of Biochemistry and Immunology, Trinity College Dublin, Dubln, Ireland, 3School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Crystal-induced arthritis, Osteoarthritis, osteoclastogenesis and signal transduction, RANK/RANKL pathway

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Intra-articular calcium hydroxyapatite (HA) crystals are present in the majority of osteoarthritic (OA) joints. They activate macrophages, synovial fibroblasts and articular chondrocytes, resulting in increased cell proliferation and the production of pro-inflammatory cytokines and matrix metalloproteases. This suggests a pathogenic role in OA by causing extracellular matrix degradation and subchondral bone remodeling. Total joint arthroplasty is performed when conservative therapies have proved unsuccessful in OA. However, particles generated from wear of prosthetic implants also induce pro-inflammatory cytokines, which drive osteoclastogenesis through up-regulation of receptor activator of nuclear factor kappa-B (RANK) ligand, an essential cytokine for the differentiation of osteoclasts. These bone-resorbing cells drive periprosthetic osteolysis through secretion of acid and the proteolytic enzyme cathepsin K and contribute to implant loosening. Both interleukin (IL)-6 and interferon (IFN)-γ exhibit anti-osteoclastogenic activity via activation of the JAK/STAT pathway. Titanium and bone cement wear particles can inhibit this effect, via activation of mitogen-activated protein kinases (MAPK) and induction of suppressor of cytokine signaling (SOCS) proteins. As synthetic HA is used as a biomimetic to coat orthopaedic implants, we sought to 1) determine whether HA crystals promote osteoclastogenesis, 2) determine whether HA crystals alter anti-osteoclastogenic signaling by IL-6 and IFN-γ and 3) elucidate the mechanism by which HA crystals may contribute to periprosthetic osteolysis.

Methods: Murine and human macrophages were stimulated with HA crystals for 3, 6 and 24 hours and expression of RANK ligand and cathepsin K was analysed by quantitative PCR. Human osteoclast precursors were stimulated with HA crystals and MAPK activation was detected by Western blot. Osteoclast precursors were treated with HA crystals for 1 hour prior to IL-6 or IFN-γ stimulation, and phosphorylation of signal transducer and activator of transcription (STAT) 1 and 3 was detected by Western blot. Up-regulation of (SOCS) 1 and 3 was analysed by q-PCR

Results: HA crystals (50μg/ml) up-regulate RANK ligand and cathepsin K in murine and human macrophages by 3 to 5-fold. Stimulation of human osteoclast precursors with HA induces the activation of p38, JNK and ERK MAPK. Pre-treatment of human osteoclast precursors with HA crystals inhibits both IFN-γ and IL-6-induced activation of STAT1 and STAT3 respectively (figs A and B). Furthermore, HA crystals up-regulate the expression of SOCS1 and SOCS3, an effect which is reduced by MAPK inhibition.

Conclusion: Based on these studies we propose that HA crystals could contribute 1) to periprosthetic osteolysis and 2) subchondral bone remodelling in OA through up-regulation of RANK ligand, and inhibition of the anti-osteoclastogenic activity of IL-6 and IFN-γ.

Description: Macintosh HD:Users:gmccarthy:Desktop:Slide 3.jpg


Disclosure: G. M. McCarthy, None; C. C. Cunningham, None; E. M. Corr, None; A. Dunne, None.

To cite this abstract in AMA style:

McCarthy GM, Cunningham CC, Corr EM, Dunne A. Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/calcium-hydroxyapatite-crystals-inhibit-interleukin-6-and-interferon-induced-anti-osteoclastogenic-signaling-in-human-osteoclast-precursors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/calcium-hydroxyapatite-crystals-inhibit-interleukin-6-and-interferon-induced-anti-osteoclastogenic-signaling-in-human-osteoclast-precursors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology